NEW YORK, HERTFORDSHIRE, England and PITTSBURGH – April 18, 2019 – Non-profit drug developer, TB Alliance, and pharmaceutical company, Mylan […]
March 20, 2019 – Building a Tuberculosis Free World: The Lancet Commission on Tuberculosis, released today, outlines what is needed
NEW YORK, NY (March 8, 2019)—TB Alliance’s new drug application (NDA) for the novel tuberculosis (TB) drug candidate pretomanid has
NEW YORK (February 5, 2019) – TB Alliance applauds the Wellcome Trust’s commitment of over £10 million to the Drugs
January 23, 2019 – The 2018 G-FINDER report shows that while funding for tuberculosis (TB) research and development (R&D) reached
Please note: this article discusses a major plot point of Red Dead Redemption 2 For players of Red Dead Redemption
NEW YORK (January 15, 2019)—TB Alliance, a not-for-profit organization dedicated to developing new drug regimens to fight tuberculosis (TB), has
NEW YORK – Dec. 11, 2018 – Schrödinger and TB Alliance today announced a three-year research collaboration to speed the
December 4, 2018 – NEW YORK – Though global funding for tuberculosis (TB) research is beginning to move in the
[November 28, 2018, WASHINGTON, D.C.] – TB Alliance and partners were honored today as the winner of the Global Health
